Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP3550 (Firmagon) maintenance dose finding in prostate cancer
NCT00568516Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2007
- Primary completion
- Oct 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of degarelix in prostate cancer (PCa), sponsored by Astellas Pharma. Started Oct 2007; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00568516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568516.